மருந்து அடையாளம் எண்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து அடையாளம் எண்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து அடையாளம் எண்கள் Today - Breaking & Trending Today

CanaQuest Medical Corp.: CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications


(0)
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the Company or CanaQuest )
, an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing a proactive investor relations and corporate communications program, further expanding investor community and media awareness about the company s material corporate developments and future prospects.
We are delighted that a seasoned communications professional with decades of financial experience has agreed to join our team at this important time in our corporate evolution, stated CanaQuest President Paul Ramsay. We believe adding a veteran like Rob to help us present our story to a wider and receptive audience is a key asset for us moving forward. ....

United States , Steven Laviolette , Kostenloser Wertpapierhandel , Rob Rinderman , Paul Ramsay , Company Or Canaquest , Biomedical Corp , American Stock Exchange , Canaquest Medical Corp , Health Canada , Stern School , Laviolette Western University , Canaquest President Paul , Wall Street , Western University , European Journal , Quest Medical Corp , Drug Identification Numbers , Master Formations , Medical Corp , Cannabis Medical Sales , Export License , Post Traumatic Stress Disorder , Canaquest Medical , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீவன் லாவிொலேத்தே ,

Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada's First Generic Thyroid Medication


Genix Pharmaceuticals Corporation is pleased to announce that it has entered into an exclusive Canadian licensing and supply agreement (the “Agreement”) with Acme Generics LLP (“ACME”) for the manufacture, sale, marketing and distribution of Canada’s first available generic version of Synthroid® (Levothyroxine sodium), a widely prescribed treatment for hypothyroidism.
Genix Pharmaceuticals Corporation (TSXV: 
GENIX” or the “
Company“) is pleased to announce that it has entered into an exclusive Canadian licensing and supply agreement (the “Agreement”) with Acme Generics LLP (“ACME”) for the manufacture, sale, marketing and distribution of Canada’s first available generic version of Synthroid® (Levothyroxine sodium), a widely prescribed treatment for hypothyroidism. ....

Sina Pirooz , Kevin Bottomley , Acme Generics , Genix Pharmaceuticals Corporation , Mylan Pharmaceuticals , Health Canada , Pharmaceuticals Corporation , Abbreviated New Drug Submissions , Marketing Authorization , Drug Identification Numbers , Good Manufacturing Practices , கெவின் பாட்டம்லி , ஆக்மி ஜெநெரிக்ஸ் , ஜெனிக்ஸ் மருந்துகள் நிறுவனம் , மைலன் மருந்துகள் , ஆரோக்கியம் கனடா , மருந்துகள் நிறுவனம் , சந்தைப்படுத்தல் அங்கீகாரம் , மருந்து அடையாளம் எண்கள் , நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் ,